E-mail lunthesis@163.com Phone 0551-65179860-203

China's first patent granted for COVID-19 vaccine

Pub Date:2020-08-18 08:41 Source:Xinhua

China's first patent for a COVID-19 vaccine has been granted by the National Intellectual Property Administration.

The patent was jointly applied for by a research team with the Academy of Military Sciences and CanSino Biologics Inc., a Chinese high-tech biopharmaceutical company, said a report in People's Daily.

The team led by Chen Wei, a researcher at the Institute of Military Medicine under the academy, developed the recombinant COVID-19 vaccine, with the modified defective adenovirus as the vector.

In March, the vaccine became the first in China to be approved to enter clinical trials.

According to the patent abstract, the vaccine shows good immunogenicity in both mouse and guinea pig models and can induce strong cellular and humoral immune response in a short period of time. It can be produced quickly on a large scale to cope with a COVID-19 outbreak.

The vaccine has now finished phase-1 and phase-2 clinical trials, which have verified its safety and immunogenicity, said the report. Enditem


Editor:Rita

Related News
- China launches new remote sensing satellite    2020-12-28 09:42
- Scaling the heights of quantum computing to deliver real ...    2020-12-24 15:05
- East China city detects coronavirus on imported food pack...    2020-12-23 16:02
- New study offers more clues on how stars die    2020-12-23 15:36
 
photo  >>
Wuhu, Anhui: 100,000 mu of canola flowers blossoming
Guest countries of honor attract visitors at 6th CIIE
Video  >>
【网络中国节·元宵】 Happy Lantern Festival! Intangible cultural heritage in Anhui—— Fish Lantern 一夜“鱼”龙舞
2024 Chinese New Year: OMG! The God of Wealth is at your door!
People  >>
Hebei rolls out red carpet for talent
Transnational couple revives ancient dwelling in east China
Travel  >>
Huangshan listed among China's Top 10 scenic cities
China expects travel spree during May Day holiday
Contact Us
Copyright ©2000-2021 anhuinews.com All rights reserved. Reproduction in whole or in part without permission is prohibited. 皖B2-20080023-7